233 related articles for article (PubMed ID: 35069597)
1. Immune Dysfunctions of CD56
Cao WJ; Zhang XC; Wan LY; Li QY; Mu XY; Guo AL; Zhou MJ; Shen LL; Zhang C; Fan X; Jiao YM; Xu RN; Zhou CB; Yuan JH; Wang SQ; Wang FS; Song JW
Front Immunol; 2021; 12():811091. PubMed ID: 35069597
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the Characteristics of TIGIT-Expressing CD3
Zhang X; Lu X; Cheung AKL; Zhang Q; Liu Z; Li Z; Yuan L; Wang R; Liu Y; Tang B; Xia H; Wu H; Zhang T; Su B
Front Immunol; 2021; 12():602492. PubMed ID: 33717085
[TBL] [Abstract][Full Text] [Related]
3. High CD56++CD16- natural killer (NK) cells among suboptimal immune responders after four years of suppressive antiretroviral therapy in an African adult HIV treatment cohort.
Bayigga L; Nabatanzi R; Sekiziyivu PN; Mayanja-Kizza H; Kamya MR; Kambugu A; Olobo J; Kiragga A; Kirimunda S; Joloba M; Nakanjako D
BMC Immunol; 2014 Jan; 15():2. PubMed ID: 24483185
[TBL] [Abstract][Full Text] [Related]
4. NK-associated receptors on CD8 T cells from treatment-naive HIV-infected individuals: defective expression of CD56.
Tarazona R; DelaRosa O; Casado JG; Torre-Cisneros J; Villanueva JL; Galiani MD; Peña J; Solana R
AIDS; 2002 Jan; 16(2):197-200. PubMed ID: 11807303
[TBL] [Abstract][Full Text] [Related]
5. CD56-negative NK cells with impaired effector function expand in CMV and EBV co-infected healthy donors with age.
Müller-Durovic B; Grählert J; Devine OP; Akbar AN; Hess C
Aging (Albany NY); 2019 Jan; 11(2):724-740. PubMed ID: 30686790
[TBL] [Abstract][Full Text] [Related]
6. CD56negCD16⁺ NK cells are activated mature NK cells with impaired effector function during HIV-1 infection.
Milush JM; López-Vergès S; York VA; Deeks SG; Martin JN; Hecht FM; Lanier LL; Nixon DF
Retrovirology; 2013 Dec; 10():158. PubMed ID: 24351015
[TBL] [Abstract][Full Text] [Related]
7. CD56
Judge CJ; Kostadinova L; Sherman KE; Butt AA; Falck-Ytter Y; Funderburg NT; Landay AL; Lederman MM; Sieg SF; Sandberg JK; Anthony DD
J Leukoc Biol; 2017 Jul; 102(1):171-184. PubMed ID: 28400540
[TBL] [Abstract][Full Text] [Related]
8. Perturbation of the natural killer cell compartment during primary human immunodeficiency virus 1 infection primarily involving the CD56 bright subset.
Mantegani P; Tambussi G; Galli L; Din CT; Lazzarin A; Fortis C
Immunology; 2010 Feb; 129(2):220-33. PubMed ID: 19824914
[TBL] [Abstract][Full Text] [Related]
9. NK cells of HIV-1-infected patients with poor CD4
Giuliani E; Vassena L; Di Cesare S; Malagnino V; Desimio MG; Andreoni M; Barnaba V; Doria M
Immunol Lett; 2017 Oct; 190():185-193. PubMed ID: 28826739
[TBL] [Abstract][Full Text] [Related]
10. Brief Report: Increased Frequency of CD39+ CD56bright Natural Killer Cells in HIV-1 Infection Correlates With Immune Activation and Disease Progression.
Dierks P; Wroblewski R; Eberhard JM; Martrus G; Degen O; Hertling S; Schmiedel S; Lunemann S; Hüfner A; Lohse AW; Altfeld M; van Lunzen J; Schulze Zur Wiesch J
J Acquir Immune Defic Syndr; 2017 Apr; 74(4):467-472. PubMed ID: 27930600
[TBL] [Abstract][Full Text] [Related]
11. CD56
Ma M; Yin X; Zhao X; Guo C; Zhu X; Liu T; Yang M; Zhang Z; Fu Y; Liu J; Xu J; Ding H; Han X; Chu Z; Shang H; Jiang Y
J Leukoc Biol; 2019 Dec; 106(6):1313-1323. PubMed ID: 31483071
[TBL] [Abstract][Full Text] [Related]
12. Proteome analysis of human CD56
Voigt J; Malone DFG; Dias J; Leeansyah E; Björkström NK; Ljunggren HG; Gröbe L; Klawonn F; Heyner M; Sandberg JK; Jänsch L
Eur J Immunol; 2018 Sep; 48(9):1456-1469. PubMed ID: 29999523
[TBL] [Abstract][Full Text] [Related]
13. Healthy Neonates Possess a CD56-Negative NK Cell Population with Reduced Anti-Viral Activity.
Jacobson A; Bell F; Lejarcegui N; Mitchell C; Frenkel L; Horton H
PLoS One; 2013; 8(6):e67700. PubMed ID: 23805324
[TBL] [Abstract][Full Text] [Related]
14. Polyfunctional natural killer cells with a low activation profile in response to Toll-like receptor 3 activation in HIV-1-exposed seronegative subjects.
Lima JF; Oliveira LMS; Pereira NZ; Duarte AJS; Sato MN
Sci Rep; 2017 Apr; 7(1):524. PubMed ID: 28373665
[TBL] [Abstract][Full Text] [Related]
15. Impaired natural killer cell-induced antibody-dependent cell-mediated cytotoxicity is associated with human immunodeficiency virus-1 disease progression.
Jia M; Li D; He X; Zhao Y; Peng H; Ma P; Hong K; Liang H; Shao Y
Clin Exp Immunol; 2013 Jan; 171(1):107-16. PubMed ID: 23199330
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of invariant natural killer T-cell and natural killer cell activation correlate with disease progression in HIV-1 and HIV-2 infections.
Bächle SM; Malone DF; Buggert M; Karlsson AC; Isberg PE; Biague AJ; Norrgren H; Medstrand P; Moll M; Sandberg JK; Jansson M;
AIDS; 2016 Jul; 30(11):1713-22. PubMed ID: 27163705
[TBL] [Abstract][Full Text] [Related]
17. Timing of Antiretroviral Therapy Initiation Determines Rectal Natural Killer Cell Populations.
Utay NS; Vigil KJ; Somasunderam A; Aulicino PC; Smulevitz B; Chiadika S; Wolf DS; Kimata JT; Arduino RC
AIDS Res Hum Retroviruses; 2020 Apr; 36(4):314-323. PubMed ID: 31838858
[TBL] [Abstract][Full Text] [Related]
18. Poorly cytotoxic terminally differentiated CD56
Forconi CS; Cosgrove CP; Saikumar-Lakshmi P; Nixon CE; Foley J; Ong'echa JM; Otieno JA; Alter G; Münz C; Moormann AM
Blood Adv; 2018 May; 2(10):1101-1114. PubMed ID: 29764843
[TBL] [Abstract][Full Text] [Related]
19. Terminal Differentiation of CD56(dim)CD16(+) Natural Killer Cells Is Associated with Increase in Natural Killer Cell Frequencies After Antiretroviral Treatment in HIV-1 Infection.
Ahmad F; Tufa DM; Mishra N; Jacobs R; Schmidt RE
AIDS Res Hum Retroviruses; 2015 Dec; 31(12):1206-12. PubMed ID: 26352913
[TBL] [Abstract][Full Text] [Related]
20. Changes in NK cell counts and receptor expressions and emergence of CD3(dim)/CD56+ cells in HIV-1 infected patients in China.
Fu GF; Hao S; Zhao JL; Xu XQ; Guo HX; Hu HY; Yang HT; Li L; Xu JS; Qiu T; Huan XP; Hou YY
Viral Immunol; 2009 Apr; 22(2):105-16. PubMed ID: 19326997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
